Review
Published on 26 May 2022
The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.874823
- 3,167 views
- 4 citations
Type at least 3 characters
1,768 articles
Articles
Review
Published on 26 May 2022
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.873994
- 11,994 views
- 52 citations
Review
Published on 26 May 2022
Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.835549
- 4,638 views
- 8 citations
Systematic Review
Published on 25 May 2022
What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.887332
- 2,818 views
- 8 citations
Review
Published on 25 May 2022
Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.884369
- 5,002 views
- 16 citations
Original Research
Published on 25 May 2022
LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation Under Hypoxia
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.882372
- 3,715 views
- 11 citations
Systematic Review
Published on 25 May 2022
LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.767750
- 3,007 views
- 2 citations
Review
Published on 24 May 2022
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.875188
- 6,556 views
- 8 citations
Original Research
Published on 23 May 2022
Discovery of Novel Tetrahydro-β-carboline Containing Aminopeptidase N Inhibitors as Cancer Chemosensitizers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.894842
- 2,115 views
- 4 citations
Mini Review
Published on 20 May 2022
The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.904887
- 4,795 views
- 11 citations
Review
Published on 19 May 2022
The Biological and Molecular Function of LINC00665 in Human Cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.886034
- 1,641 views
- 2 citations
Correction
Published on 19 May 2022
Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.917378
- 1,164 views
- 2 citations
Review
Published on 19 May 2022
The Role of Nonapoptotic Programmed Cell Death — Ferroptosis, Necroptosis, and Pyroptosis — in Pancreatic Ductal Adenocarcinoma Treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.872883
- 5,581 views
- 7 citations
Original Research
Published on 17 May 2022
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.877194
- 4,988 views
- 9 citations
Original Research
Published on 16 May 2022
Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.884559
- 3,261 views
- 12 citations
Original Research
Published on 13 May 2022
Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.885186
- 4,528 views
- 4 citations